<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02385006</url>
  </required_header>
  <id_info>
    <org_study_id>2012.727</org_study_id>
    <nct_id>NCT02385006</nct_id>
  </id_info>
  <brief_title>Thromboelastography and Pancreas-kidney Transplantation</brief_title>
  <acronym>TEG-PKT</acronym>
  <official_title>Thromboelastographic Profile During Simultaneous Pancreas-kidney Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Type of study:Prospective, single-center, non-therapeutic, of routine care No randomization,
      no modifications of the usual care, study results are not available for the physicians in
      charge of the patient.

      Objectives:

        -  The main objective of this study is to evaluate the ability of the thromboelastogram
           (ROTEM®) to detect clotting disorders related to pancreas-kidney transplantation,
           comparing ROTEM ® profiles during the perioperative period of two different types of
           transplantation (kidney alone and simultaneous pancreas-kidney)

        -  The secondary objectives are:

             1. To assess the incidence and type of coagulation disorders during the perioperative
                period of these two types of transplantation

             2. To study correlation values between thrombolelastogram and standard coagulation
                parameters

      Population study:

        -  Evaluated group: 40 pancreas-kidney recipients

        -  Control group: 80 kidney recipients

        -  Recruitment periods: 24 months

        -  Patient Monitoring: 48 hours

        -  Total duration of the study: 36 months.

        -  Ethics: Study of routine care. Oral and written information given to patients.
           Validation of the study protocol by the local ethics committee (CPP Sud Est II: Protocol
           No. HCL / P 2012.727)
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Actual">November 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Thromboelastogram (ROTEM®) channels (APTEM, EXTEM, INTEM, FIBTEM) monitoring</measure>
    <time_frame>preoperative period</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Thromboelastogram (ROTEM®) channels (APTEM, EXTEM, INTEM, FIBTEM) monitoring</measure>
    <time_frame>45 min after transplant unclamp</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Thromboelastogram (ROTEM®) channels (APTEM, EXTEM, INTEM, FIBTEM) monitoring</measure>
    <time_frame>Intensice Care Unit admission</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Thromboelastogram (ROTEM®) channels (APTEM, EXTEM, INTEM, FIBTEM) monitoring</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Thromboelastogram (ROTEM®) channels (APTEM, EXTEM, INTEM, FIBTEM) monitoring</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>standard coagulation parameters</measure>
    <time_frame>preoperative period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>standard coagulation parameters</measure>
    <time_frame>45 min after transplant unclamp</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>standard coagulation parameters</measure>
    <time_frame>Intensice Care Unit admission</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>standard coagulation parameters</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>standard coagulation parameters</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">152</enrollment>
  <condition>Blood Coagulation</condition>
  <arm_group>
    <arm_group_label>Arm kidney transplanted</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Arm kidney transplanted: all patients who receive kidney transplantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm pancreas-kidney transplanted</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Arm pancreas-kidney transplanted: all patients who receive pancreas-kidney transplantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <arm_group_label>Arm kidney transplanted</arm_group_label>
    <arm_group_label>Arm pancreas-kidney transplanted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men, women &gt; 18 years old

          -  Kidney or pancreas-kidney recipients

          -  Not opposed to research

          -  With no legal protection

          -  Affiliated to social security system

        Exclusion Criteria:

        -Enrollment in an other research protocol, incompatible with the trial according to the
        investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Anesthesiology and Critical Care Medicine, Edouard Herriot Hospital, Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2015</study_first_submitted>
  <study_first_submitted_qc>March 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>March 4, 2015</last_update_submitted>
  <last_update_submitted_qc>March 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thromboelastography</keyword>
  <keyword>simulatneous pancreas-kidney transplantation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancrelipase</mesh_term>
    <mesh_term>Pancreatin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

